Guideline endorses salivary liquid biopsy for early oral cancer detection

The ADA's 2026 living evidence‑informed guideline, published in JADA, highlights that salivary liquid‑biopsy panels achieved 92% sensitivity and 88% specificity for detecting early‑stage oral squamous cell carcinoma. Adoption of chair‑side saliva testing is recommended to improve survival outcomes through earlier intervention.